Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Athersys Inc (NQ: ATHX )

1.020 +0.020 (+2.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,662
Open 1.000
Bid (Size) 0.9161 (1)
Ask (Size) 1.070 (1)
Prev. Close 1.000
Today's Range 0.9618 - 1.070
52wk Range 0.5031 - 10.50
Shares Outstanding 226,255,093
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Patient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic Trauma
From Athersys, Inc.
Via Business Wire
Athersys Restructures Debt with Supplier
From Athersys, Inc.
Via Business Wire

Performance

YTD
+26.24%
+26.24%
1 Month
+23.98%
+23.98%
3 Month
-33.33%
-33.33%
6 Month
+79.45%
+79.45%
1 Year
-86.31%
-86.31%

More News

Read More
Athersys Reports First Quarter 2023 Financial Results and Business Highlights
From Athersys, Inc.
Via Business Wire
Athersys Earnings Perspective: Return On Capital Employed
Via Benzinga
Athersys to Participate in Three Upcoming Conferences
From Athersys, Inc.
Via Business Wire
Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference
From Athersys, Inc.
Via Business Wire
Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference
From Athersys, Inc.
Via Business Wire
Athersys, Inc. Announces Closing of $3.7 Million Registered Direct Offering and Concurrent Private Placement
From Athersys, Inc.
Via Business Wire
Why Athersys Shares Are Falling During Tuesday's Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Athersys, Inc. Announces $3.7 Million Registered Direct Offering and Concurrent Private Placement
From Athersys, Inc.
Via Business Wire
Athersys to Host Business Update Conference Call on April 20th
From Athersys, Inc.
Via Business Wire
Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From Athersys, Inc.
Via Business Wire
Athersys Announces Successful Type B Meeting with the FDA
From Athersys, Inc.
Via Business Wire
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
Via Benzinga
Athersys Expands IP Protection with First New Patent for SIFU® Technology
From Athersys, Inc.
Via Business Wire
Athersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion
From Athersys, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Athersys to Host Business Update Conference Call on February 14th
From Athersys, Inc.
Via Business Wire
Athersys to Participate in International Stroke Conference and BioProcess International
From Athersys, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in January
From Athersys, Inc.
Via Business Wire
Athersys Provides MultiStem Clinical Update
From Athersys, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.